Francis Wong

Francis Wong is an associate scientist at Verve Therapeutics, with expertise in molecular biology techniques and NGS platforms. Prior to joining Verve, he worked at Vertex Pharmaceuticals, where he worked on developing gene-editing therapies based on CRISPR/Cas9 mechanisms targeting Duchenne’s Muscular Dystrophy. He received his M.S. in Physiology from McGill University while researching the effects of particulate matter on respiratory health.